Study suggests COVID-19 vaccination lowers incidence of arterial thromboses
A second dose of the vaccine lowered the incidence of conditions such as heart attack or stroke
Read More
Tag: University of Bristol
Study reveals two proteins that may contribute to stroke recurrence or other MACEs
The life-threatening medical condition affects 100,000 people in the UK every year
Read More
Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Read More
Female cancer survivors at low risk of developing obstetric complications
According to WHO, around 15% of pregnant women will develop an obstetric complication
Read More
Scientists uncover new disease-driving mechanism to treat atheroschlerosis
Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease
Read More
Researchers call to reduce repeat antibiotic prescriptions for respiratory tract infections
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Read More
UK study finds screening with a PSA test in prostate cancer can lead to overdiagnosis
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men
Read More
Parkinson’s UK awards over £1.8m for nine research projects
Around 145,000 people in the UK are living with Parkinson’s disease
Read More
New University of Bristol study to aid strep A vaccine development
The study will offer new insights into the immune system’s response to iGAS
Read More
Corticosteroids boost survival rates for COVID-19 patients
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Read More
New research could spot people most susceptible to infection after knee replacement surgery
Patients who are under 60 years of age, males, those with chronic pulmonary disease, diabetes, or liver disease, and people with a higher body mass index are at increased risk.
Read More
Experimental Parkinson’s therapy shows promise
A novel experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients.
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
